TOTH FINANCIAL ADVISORY CORP
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 866780
LEESBURG, VA
Position in MDGL
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$1,046,940
-$117,740 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TOTH FINANCIAL ADVISORY CORP holds $6,027,293 across 24 Biotechnology names. MDGL ranks #4 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
13,695 | $1,288,973 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
6,600 | $1,247,730 | |
| 3 | ASND |
Ascendis Pharma A/S
|
5,450 | $1,246,578 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
2,000 | $1,046,940 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
10,000 | $869,700 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306 | $136,641 | |
| 7 | ARGX |
Argenx SE
|
145 | $105,886 | |
| 8 | EYPT |
EyePoint, Inc.
|
2,001 | $25,792 |
All Filings in MDGL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,046,940 | 2,000 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,164,680 | 2,000 | Shares | Sole | 2026-01-20 | |
| 2022-03-31 | $1,962 | 20 | Shares | Sole | 2022-04-26 | |
| No filing history on record for this holder in this stock. | ||||||